ARCHIVES

In Setback For Generics, Court Overturns FDA.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

Basic Biology Progress, Improved Survival Since 1971 Described By DeVita At Senate Hearing

February 27, 1981

In Brief: House Passes Bill Extending Saccharin Status To 1981; Execs No Enthusiastic Over New SES

August 3, 1979

Obey Convinces House Hew Subcommittee to Cut $17 Million Control, Give It To Bioassays

June 1, 1979

Only Seven Of 66 “Benign” Breast Cancer Turn Out to Be Doubtful

November 25, 1977

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

‘Major Discover’ At FCRDC Is NF1 Gene, Report Says

November 30, 1990